{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:57Z","timestamp":1792806057968,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04387-5","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:13:44Z","timestamp":1779455624000},"page":"5451-5461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Whole-brain radiotherapy with simultaneous integrated boost in treatment of patients with brain metastases: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9790-2803","authenticated-orcid":false,"given":"Dominik","family":"Wr\u00f3bel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Sobieryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Kozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Potocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Seweryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u0119drzej","family":"Borowczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"4387_CR1","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/NEUONC\/NOAB101","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021;23:1447. https:\/\/doi.org\/10.1093\/NEUONC\/NOAB101.","journal-title":"Neuro Oncol"},{"key":"4387_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/J.NEUCHI.2021.04.001","volume":"68","author":"DK Mitchell","year":"2021","unstructured":"Mitchell DK, Kwon HJ, Kubica PA, Huff WX, O\u2019Regan R, Dey M. Brain metastases: an update on multi-disciplinary approach of clinical management. Neurochirurgie. 2021;68:69. https:\/\/doi.org\/10.1016\/J.NEUCHI.2021.04.001.","journal-title":"Neurochirurgie"},{"key":"4387_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314\/SUPPL_FILE\/TX-BRAIN-METS-SLIDES-FINAL.PPS","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, et al. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol. 2022;40:492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314\/SUPPL_FILE\/TX-BRAIN-METS-SLIDES-FINAL.PPS.","journal-title":"J Clin Oncol"},{"key":"4387_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003869.PUB4","author":"MN Tsao","year":"2018","unstructured":"Tsao MN, Xu W, Wong RKS, Lloyd N, Laperriere N, Sahgal A, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. The Cochrane database of systematic reviews. 2018. https:\/\/doi.org\/10.1002\/14651858.CD003869.PUB4.","journal-title":"The Cochrane database of systematic reviews"},{"key":"4387_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1010428317702903","volume":"39","author":"M Khan","year":"2017","unstructured":"Khan M, Lin J, Liao G, Li R, Wang B, Xie G, et al. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: review and meta-analysis. Tumor Biol. 2017;39:1\u201314. https:\/\/doi.org\/10.1177\/1010428317702903.","journal-title":"Tumor Biol"},{"key":"4387_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA. 2016;316:401\u20139. https:\/\/doi.org\/10.1001\/jama.2016.9839.","journal-title":"JAMA"},{"key":"4387_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-025-14443-Y","author":"Z Liu","year":"2025","unstructured":"Liu Z, Du X, Deng M, Chen Y, Wu S. A retrospective propensity-matched study comparing whole-brain radiotherapy with simultaneous integrated boost to whole-brain radiotherapy alone for brain metastases. BMC Cancer. 2025. https:\/\/doi.org\/10.1186\/S12885-025-14443-Y.","journal-title":"BMC Cancer"},{"key":"4387_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/S11060-020-03405-Y","volume":"147","author":"J Zhong","year":"2020","unstructured":"Zhong J, Waldman AD, Kandula S, Eaton BR, Prabhu RS, Huff SB, et al. Outcomes of whole-brain radiation with simultaneous in-field boost (SIB) for the treatment of brain metastases. J Neurooncol. 2020;147:117\u201323. https:\/\/doi.org\/10.1007\/S11060-020-03405-Y.","journal-title":"J Neurooncol"},{"key":"4387_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/S13014-019-1255-7","author":"A Jiang","year":"2019","unstructured":"Jiang A, Sun W, Zhao F, Wu Z, Shang D, Yu Q, et al. Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases. Radiat Oncol. 2019. https:\/\/doi.org\/10.1186\/S13014-019-1255-7.","journal-title":"Radiat Oncol"},{"key":"4387_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/J.MEDDOS.2012.07.010","volume":"38","author":"X Liang","year":"2013","unstructured":"Liang X, Ni L, Hu W, Chen W, Ying S, Gong Q, et al. A planning study of simultaneous integrated boost with forward IMRT for multiple brain metastases. Med Dosim. 2013;38:115\u20136. https:\/\/doi.org\/10.1016\/J.MEDDOS.2012.07.010.","journal-title":"Med Dosim"},{"key":"4387_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/BIOLOGY12040585","volume":"12","author":"L Johannwerner","year":"2023","unstructured":"Johannwerner L, Werner EM, Cremers F, Yu NY, Rades D, Johannwerner L. The first survival score for patients treated with whole-brain radiotherapy plus simultaneous integrated boost for brain metastases. Biology. 2023;12:585. https:\/\/doi.org\/10.3390\/BIOLOGY12040585.","journal-title":"Biology"},{"key":"4387_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"4387_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"key":"4387_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.I4919","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Online). 2016. https:\/\/doi.org\/10.1136\/BMJ.I4919.","journal-title":"BMJ (Online)"},{"key":"4387_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/BMJ.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360. https:\/\/doi.org\/10.1136\/BMJ.327.7414.557.","journal-title":"BMJ"},{"key":"4387_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/JRSM.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97\u2013111. https:\/\/doi.org\/10.1002\/JRSM.12.","journal-title":"Res Synth Methods"},{"key":"4387_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12874-021-01381-Z\/FIGURES\/5","volume":"21","author":"TH Barker","year":"2021","unstructured":"Barker TH, Migliavaca CB, Stein C, Colpani V, Falavigna M, Aromataris E, et al. Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol. 2021;21:1\u20139. https:\/\/doi.org\/10.1186\/S12874-021-01381-Z\/FIGURES\/5.","journal-title":"BMC Med Res Methodol"},{"key":"4387_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https:\/\/doi.org\/10.1186\/1745-6215-8-16.","journal-title":"Trials"},{"key":"4387_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/S12672-024-01176-W","author":"L Agolli","year":"2024","unstructured":"Agolli L, Nicosia L, Hilger T, Iancu G, Exeli AK, Eul B, et al. Outcome of whole brain irradiation with a dose-escalated simultaneous-integrated boost in patients with multiple large and\/or diffuse brain metastases: real live data and review of the literature. Discov Oncol. 2024. https:\/\/doi.org\/10.1007\/S12672-024-01176-W.","journal-title":"Discov Oncol"},{"key":"4387_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/S11060-016-2128-7","volume":"128","author":"G Bauman","year":"2016","unstructured":"Bauman G, Yartsev S, Roberge D, MacRae R, Roa W, Panet-Raymond V, et al. Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases. J Neurooncol. 2016;128:431\u20136. https:\/\/doi.org\/10.1007\/S11060-016-2128-7.","journal-title":"J Neurooncol"},{"key":"4387_CR21","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.7150\/JCA.95804","volume":"15","author":"Q Bi","year":"2024","unstructured":"Bi Q, Shen J, Li P, Zeng Y, Lian X, Zhang F. Efficacy of whole-brain radiotherapy plus simultaneous integrated boost (SIB-WBRT) for lung cancer brain metastases. J Cancer. 2024;15:4636\u201342. https:\/\/doi.org\/10.7150\/JCA.95804.","journal-title":"J Cancer"},{"key":"4387_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4103\/NEUROL-INDIA.NEUROL-INDIA-D-24-00589","volume":"73","author":"AJ Christina","year":"2025","unstructured":"Christina AJ, Pasha T, Valuvil NB, Krishna U, Manikandan PS, Naveen T, et al. Hippocampal avoidance -whole brain radiotherapy (HA-WBRT) with simultaneous integrated boost (SIB) with memantine in brain metastasis. Neurol India. 2025;73:710\u20135. https:\/\/doi.org\/10.4103\/NEUROL-INDIA.NEUROL-INDIA-D-24-00589.","journal-title":"Neurol India"},{"key":"4387_CR23","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.7150\/JCA.26547","volume":"9","author":"Y Dong","year":"2018","unstructured":"Dong Y, Zhang Y, Zhang T, Fan M, Zhu J, Li B, et al. Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy based on MRI-CT fusion in patients with brain metastases of non-small cell lung cancer. J Cancer. 2018;9:4477\u201383. https:\/\/doi.org\/10.7150\/JCA.26547.","journal-title":"J Cancer"},{"key":"4387_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2023.1220047","author":"X Dong","year":"2023","unstructured":"Dong X, Wang K, Yang H, Li Y, Hou Y, Chang J, et al. Choice of radiotherapy modality for the combined treatment of non-small cell lung cancer with brain metastases: whole-brain radiation therapy with simultaneous integrated boost or stereotactic radiosurgery. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/FONC.2023.1220047.","journal-title":"Front Oncol"},{"key":"4387_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/S00432-020-03359-8","volume":"147","author":"TQ Du","year":"2021","unstructured":"Du TQ, Li X, Zhong WS, Tian JD, Zhao YX, Liu D. Brain metastases of lung cancer: comparison of survival outcomes among whole brain radiotherapy, whole brain radiotherapy with consecutive boost, and simultaneous integrated boost. J Cancer Res Clin Oncol. 2021;147:569\u201377. https:\/\/doi.org\/10.1007\/S00432-020-03359-8.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4387_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1533034614566993","volume":"15","author":"KH Kim","year":"2016","unstructured":"Kim KH, Cho BC, Lee CG, Kim HR, Suh YG, Kim JW, et al. Hippocampus-sparing whole-brain radiotherapy and simultaneous integrated boost for multiple brain metastases from lung adenocarcinoma: early response and dosimetric evaluation. Technol Cancer Res Treat. 2016;15:122\u20139. https:\/\/doi.org\/10.1177\/1533034614566993.","journal-title":"Technol Cancer Res Treat"},{"key":"4387_CR27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4143\/CRT.2018.206","volume":"51","author":"Y Kim","year":"2019","unstructured":"Kim Y, Kim SH, Lee JH, Kang DG. Verification of low risk for perihippocampal recurrence in patients with brain metastases who received whole-brain radiotherapy with hippocampal avoidance. Cancer Res Treat. 2019;51:568\u201375. https:\/\/doi.org\/10.4143\/CRT.2018.206.","journal-title":"Cancer Res Treat"},{"key":"4387_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/S11060-020-03491-Y","volume":"148","author":"ES Lebow","year":"2020","unstructured":"Lebow ES, Hwang WL, Zieminski S, Wang Y, Niemierko A, Mehan WA, et al. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases. J Neurooncol. 2020;148:81\u20138. https:\/\/doi.org\/10.1007\/S11060-020-03491-Y.","journal-title":"J Neurooncol"},{"key":"4387_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-024-12559-1","author":"Z Li","year":"2024","unstructured":"Li Z, Wang J, Deng L, Zhai Y, Zhang T, Bi N, et al. Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study. BMC Cancer. 2024. https:\/\/doi.org\/10.1186\/S12885-024-12559-1.","journal-title":"BMC Cancer"},{"key":"4387_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.21037\/JTD-22-96\/COIF)","volume":"14","author":"J Ma","year":"2022","unstructured":"Ma J, Bi J, Tuo X, Pi G, Li Y, Li Y, et al. Efficacy and safety of apatinib combined with whole-brain radiation therapy with a simultaneous integrated boost for brain metastases from non-small cell lung cancer: a multicenter retrospective study. J Thorac Dis. 2022;14:455\u201363. https:\/\/doi.org\/10.21037\/JTD-22-96\/COIF).","journal-title":"J Thorac Dis"},{"key":"4387_CR31","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1002\/CNCR.32787","volume":"126","author":"I Popp","year":"2020","unstructured":"Popp I, Rau S, Hintz M, Schneider J, Bilger A, Fennell JT, et al. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases. Cancer. 2020;126:2694\u2013703. https:\/\/doi.org\/10.1002\/CNCR.32787.","journal-title":"Cancer"},{"key":"4387_CR32","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.21873\/ANTICANRES.16482","volume":"43","author":"D Rades","year":"2023","unstructured":"Rades D, Johannwerner L, Werner EM, Cremers F, Gliemroth J, Yu NY. Whole-brain Radiotherapy With or Without a Simultaneous Integrated Boost for Treatment of Brain Metastases. Anticancer Res. 2023;43:3107\u201312. https:\/\/doi.org\/10.21873\/ANTICANRES.16482.","journal-title":"Anticancer Res"},{"key":"4387_CR33","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ijrobp.2010.03.047","volume":"80","author":"G Rodrigues","year":"2011","unstructured":"Rodrigues G, Yartsev S, Yaremko B, Perera F, Dar AR, Hammond A, et al. Phase i trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases. Int J Radiat Oncol Biol Phys. 2011;80:1128\u201333. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.03.047.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4387_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-025-14593-Z","author":"X Shan","year":"2025","unstructured":"Shan X, Wang W, Zhang T, Liu W, Wang J, Wang X, et al. Comparison the efficiency of whole brain radiotherapy and simultaneous integrated boost in small cell lung cancer with brain metastases. BMC Cancer. 2025. https:\/\/doi.org\/10.1186\/S12885-025-14593-Z.","journal-title":"BMC Cancer"},{"key":"4387_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/10732748251319489","author":"W Tao","year":"2025","unstructured":"Tao W, Jiang C, Xie J, Liu W, Wang S, Zhang J, et al. Whole-brain radiotherapy simultaneous integrated boost intensity-modulated radiotherapy combined with Anlotinib in the treatment of brain metastases. Cancer Control. 2025. https:\/\/doi.org\/10.1177\/10732748251319489.","journal-title":"Cancer Control"},{"key":"4387_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/2278-330X.149927","volume":"4","author":"V Tiwari","year":"2015","unstructured":"Tiwari V, Pande SC, Verma K, Goel S. Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: A feasible technique for developing countries. South Asian J Cancer. 2015;4:11\u20134. https:\/\/doi.org\/10.4103\/2278-330X.149927.","journal-title":"South Asian J Cancer"},{"key":"4387_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/J.PRRO.2011.03.005","volume":"1","author":"JA Vargo","year":"2011","unstructured":"Vargo JA, Plants BA, Mihailidis DN, Mallah J, Plants M, Welch CA, et al. Early clinical outcomes for 3 radiation techniques for brain metastases: focal versus whole-brain. Pract Radiat Oncol. 2011;1:261\u201370. https:\/\/doi.org\/10.1016\/J.PRRO.2011.03.005.","journal-title":"Pract Radiat Oncol"},{"key":"4387_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-023-11286-3","author":"X Wang","year":"2023","unstructured":"Wang X, Chen J, Lei Z, Chen H, Zhang Y, Liu G, et al. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus\u2011avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions. BMC Cancer. 2023. https:\/\/doi.org\/10.1186\/S12885-023-11286-3.","journal-title":"BMC Cancer"},{"key":"4387_CR39","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/NEUONC\/NOAA092","volume":"22","author":"KD Westover","year":"2020","unstructured":"Westover KD, Travis Mendel J, Dan T, Kumar K, Gao A, Pulipparacharuv S, et al. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer. Neuro Oncol. 2020;22:1831\u20139. https:\/\/doi.org\/10.1093\/NEUONC\/NOAA092.","journal-title":"Neuro Oncol"},{"key":"4387_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.70112","author":"J Xu","year":"2025","unstructured":"Xu J, Yang Y, Chen T, Liu D, Yuan Y, Xu L. The efficacy and safety of brain radiotherapy combined with immune checkpoint inhibitors (ICIs) for small-cell lung cancer (SCLC) patients with brain metastases (BMs). Thorac Cancer. 2025. https:\/\/doi.org\/10.1111\/1759-7714.70112.","journal-title":"Thorac Cancer"},{"key":"4387_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007715","author":"J Yang","year":"2017","unstructured":"Yang J, Zhan W, Zhang H, Song T, Jia Y, Xu H, et al. Intensity-modulated radiation therapy for patients with 1 to 3 brain metastases in recursive partitioning analysis class 3. Medicine. 2017. https:\/\/doi.org\/10.1097\/MD.0000000000007715.","journal-title":"Medicine"},{"key":"4387_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-024-12739-Z","author":"N Yao","year":"2024","unstructured":"Yao N, Qin Z, Chen M, Hu L, Ma J, Lu J, et al. Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer. BMC Cancer. 2024. https:\/\/doi.org\/10.1186\/S12885-024-12739-Z.","journal-title":"BMC Cancer"},{"key":"4387_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-023-11739-9","author":"K Zhang","year":"2023","unstructured":"Zhang K, Zhang T, Guo Z, Zhao F, Li J, Li Y, et al. Adding simultaneous integrated boost to whole brain radiation therapy improved intracranial tumour control and minimize radiation-induced brain injury risk for the treatment of brain metastases. BMC Cancer. 2023. https:\/\/doi.org\/10.1186\/S12885-023-11739-9.","journal-title":"BMC Cancer"},{"key":"4387_CR44","doi-asserted-by":"publisher","DOI":"10.7717\/PEERJ.17696","author":"H Zhang","year":"2024","unstructured":"Zhang H, Wu Q, Li L, Wang L, Zhong Y. Whole-brain radiation therapy plus simultaneous integrated boost for brain metastases from breast cancers. PeerJ. 2024. https:\/\/doi.org\/10.7717\/PEERJ.17696.","journal-title":"PeerJ"},{"key":"4387_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-9-117","author":"L Zhou","year":"2014","unstructured":"Zhou L, Liu J, Xue J, Xu Y, Gong Y, Deng L, et al. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer. Radiat Oncol. 2014. https:\/\/doi.org\/10.1186\/1748-717X-9-117.","journal-title":"Radiat Oncol"},{"key":"4387_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.631422","author":"B Lin","year":"2021","unstructured":"Lin B, Huang D, Du H, Fan J, Zhang Y, Feng G, et al. Whole-brain radiation therapy with simultaneous integrated boost versus whole-brain radiation therapy plus stereotactic radiosurgery for the treatment of brain metastasis from lung cancer. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/FONC.2021.631422.","journal-title":"Front Oncol"},{"key":"4387_CR47","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.jtho.2025.04.007","volume":"20","author":"BH Gr\u00f8nberg","year":"2025","unstructured":"Gr\u00f8nberg BH, Killingberg KT, Fl\u00f8tten \u00d8, Bjaan\u00e6s MM, Brustugun OT, Madebo T, et al. High-dose versus standard-dose twice-daily thoracic radiotherapy in limited-stage sclc: final survival data, long-term toxicity, and relapse patterns in a randomized, open-label, phase ii trial. J Thorac Oncol. 2025;20:1108\u201319. https:\/\/doi.org\/10.1016\/j.jtho.2025.04.007.","journal-title":"J Thorac Oncol"},{"key":"4387_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/S12967-021-03161-1","author":"G Deng","year":"2021","unstructured":"Deng G, Zhang Y, Ke J, Wang Q, Qin H, Li J, et al. Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis. J Transl Med. 2021. https:\/\/doi.org\/10.1186\/S12967-021-03161-1.","journal-title":"J Transl Med"},{"key":"4387_CR49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13014-020-01509-3","volume":"15","author":"M Ni","year":"2020","unstructured":"Ni M, Jiang A, Liu W, Sheng Y, Zeng H, Liu N, et al. Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study. Radiat Oncol. 2020;15:70. https:\/\/doi.org\/10.1186\/s13014-020-01509-3.","journal-title":"Radiat Oncol"},{"key":"4387_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-283","volume":"12","author":"D Steinmann","year":"2012","unstructured":"Steinmann D, Paelecke-Habermann Y, Geinitz H, Aschoff R, Bayerl A, B\u00f6lling T, et al. Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases. BMC Cancer. 2012;12:283. https:\/\/doi.org\/10.1186\/1471-2407-12-283.","journal-title":"BMC Cancer"},{"key":"4387_CR51","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.ijrobp.2011.09.025","volume":"83","author":"A Caissie","year":"2012","unstructured":"Caissie A, Nguyen J, Chen E, Zhang L, Sahgal A, Clemons M, et al. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL. Int J Radiat Oncol Biol Phys. 2012;83:1238\u201345. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.09.025.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4387_CR52","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/S11060-023-04384-6","volume":"163","author":"S Leskinen","year":"2023","unstructured":"Leskinen S, Shah HA, Yaffe B, Schneider SJ, Ben-Shalom N, Boockvar JA, et al. Hippocampal avoidance in whole brain radiotherapy and prophylactic cranial irradiation: a systematic review and meta-analysis. J Neurooncol. 2023;163:515\u201327. https:\/\/doi.org\/10.1007\/S11060-023-04384-6.","journal-title":"J Neurooncol"},{"key":"4387_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf073","volume":"7","author":"A Salman","year":"2025","unstructured":"Salman A, Naeem U, Ghazanfar S, Jawed A, Farooq M. Neurocognitive outcome of HS-WBRT vs WBRT in patients with brain metastases: a systematic review and meta-analysis. Neurooncol Adv. 2025;7:vdaf073. https:\/\/doi.org\/10.1093\/noajnl\/vdaf073.","journal-title":"Neurooncol Adv"},{"key":"4387_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","volume":"112","author":"A Freites-Martinez","year":"2021","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, Viera A. CTCAE versi\u00f3n 5.0. Evaluaci\u00f3n de la gravedad de los eventos adversos dermatol\u00f3gicos de las terapias antineopl\u00e1sicas. Actas Dermosifiliogr. 2021;112:90\u20132. https:\/\/doi.org\/10.1016\/j.ad.2019.05.009.","journal-title":"Actas Dermosifiliogr"},{"key":"4387_CR55","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.1016\/S1470-2045(15)00088-1","volume":"16","author":"H Okada","year":"2015","unstructured":"Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, et al. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol. 2015;16:e534\u201342. https:\/\/doi.org\/10.1016\/S1470-2045(15)00088-1.","journal-title":"Lancet Oncol"},{"key":"4387_CR56","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(04)16250-8.","journal-title":"Lancet"},{"key":"4387_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006121.pub4","volume":"9","author":"CG Patil","year":"2017","unstructured":"Patil CG, Pricola K, Sarmiento JM, Garg SK, Bryant A, Black KL. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev. 2017;9:CD006121. https:\/\/doi.org\/10.1002\/14651858.CD006121.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"4387_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13014-016-0634-6\/TABLES\/4","volume":"11","author":"P Borghetti","year":"2016","unstructured":"Borghetti P, Pedretti S, Spiazzi L, Avitabile R, Urpis M, Foscarini F, et al. Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: Dosimetric comparison between helical and volumetric IMRT technique. Radiat Oncol. 2016;11:1\u201310. https:\/\/doi.org\/10.1186\/S13014-016-0634-6\/TABLES\/4.","journal-title":"Radiat Oncol"},{"key":"4387_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/CCO.0000000000000818","volume":"34","author":"M Krayem","year":"2022","unstructured":"Krayem M, Ghanem GE, Van Gestel D. Recent advances in radiosensitivity determinants in melanoma. Curr Opin Oncol. 2022;34:131\u20138. https:\/\/doi.org\/10.1097\/CCO.0000000000000818.","journal-title":"Curr Opin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04387-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:01:59Z","timestamp":1792803719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04387-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4387"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04387-5","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None declared.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}